BlackRock Discloses 5.0% Stake in Core Laboratories
Ticker: CLB · Form: SC 13G · Filed: Jan 22, 2024 · CIK: 1958086
Complexity: simple
Sentiment: neutral
Topics: institutional-ownership, passive-investment, oil-gas-services
TL;DR
**BlackRock just revealed a 5% stake in Core Labs, signaling institutional confidence.**
AI Summary
BlackRock Inc., a major investment firm, reported on January 22, 2024, that it beneficially owns 5.0% of Core Laboratories Inc. /DE/'s common stock as of December 31, 2023. This means BlackRock holds a significant stake in Core Laboratories, an oil and gas field services company. For investors, this indicates that a large, institutional investor sees value in Core Laboratories, potentially signaling confidence in the company's future performance.
Why It Matters
This filing shows a major institutional investor, BlackRock, has a significant stake in Core Laboratories, which can be seen as a vote of confidence in the company.
Risk Assessment
Risk Level: low — This filing indicates a stable, passive investment by a large institution, which generally reduces risk for other shareholders.
Analyst Insight
Investors should note BlackRock's significant, passive stake as a potential indicator of institutional confidence, but also understand it doesn't imply active management changes or an impending acquisition.
Key Numbers
- 5.0% — Beneficial Ownership (Percentage of Core Laboratories Inc. common stock owned by BlackRock Inc.)
Key Players & Entities
- BlackRock Inc. (company) — reporting person, beneficial owner of shares
- Core Laboratories Inc. /DE/ (company) — subject company, issuer of the securities
- 5.0% (dollar_amount) — percentage of class beneficially owned by BlackRock
- December 31, 2023 (date) — date of event requiring the filing
- January 22, 2024 (date) — filing date
Forward-Looking Statements
- BlackRock will maintain its passive stake in Core Laboratories Inc. /DE/ for the foreseeable future. (BlackRock Inc.) — high confidence, target: 2025-01-22
FAQ
What is the purpose of an SC 13G filing?
An SC 13G filing is used by institutional investors, like BlackRock Inc., to report beneficial ownership of 5% or more of a company's stock when they are passive investors and do not intend to influence or control the company. This specific filing was made under Rule 13d-1(b).
Which company is the subject of this SC 13G filing?
The subject company of this SC 13G filing is Core Laboratories Inc. /DE/, which operates in the oil, gas field services industry (SIC 1389).
Who is the reporting entity in this SC 13G filing?
The reporting entity in this SC 13G filing is BlackRock Inc., a security brokers, dealers & flotation company (SIC 6211), headquartered at 50 Hudson Yards, New York, NY.
What percentage of Core Laboratories Inc.'s common stock does BlackRock Inc. beneficially own, according to this filing?
As of December 31, 2023, BlackRock Inc. beneficially owns 5.0% of Core Laboratories Inc.'s common stock, as indicated by the filing.
What is the CUSIP number for the securities mentioned in this filing?
The CUSIP number for the Common Stock of Core Laboratories Inc. is 21867A105, as stated in the filing.
Filing Details
This Form SC 13G (Form SC 13G) was filed with the SEC on January 22, 2024 regarding Core Laboratories Inc. /DE/ (CLB).